尿酸的入院水平可以预测急性心力衰竭的尿剂总剂量吗?
Maryam Chenaghlou1, Fatemeh Abedi Mahzoon2, Sina Hamzehzadeh3
1Cardiovascular research center, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC cardiovascular disorders
|January 3, 2024
概括
血清尿酸水平与急性心力衰竭患者的利尿剂量相关. 虽然初步发现表明与死亡率有联系,但在多变量分析后,这并不显著,表明尿酸可能不是结果的可靠预测指标.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 临床结果 临床结果
背景情况:
- 血清尿酸升高与慢性心力衰竭 (CHF) 的不良结果有关.
- 心力衰竭的急性恶化在患者管理中存在独特的挑战.
- 利尿疗法是急性心力衰竭中管理液体过载的基石.
研究的目的:
- 在急性心力衰竭的住院患者中研究血清尿酸水平和利尿剂剂量之间的关系.
- 评估血清尿酸作为评估尿剂需求的潜在生物标志物.
- 作为临床评估工具,探索血清尿酸和亲脑性尿素 (pro-BNP) 之间的关联.
主要方法:
- 100名住院急性心力衰竭患者的回顾性分析.
- 数据收集包括血清尿酸水平和罗塞米德总剂量.
- 使用SPSS软件进行了统计分析,包括相关性和多变量分析,显著程度为0.05.
主要成果:
- 在血清尿酸水平和furosemide剂量之间发现了显著的正相关性 (r=0.248,P=0.017).
- 在血清尿酸水平和罗塞米德剂量之间也观察到显著的负相关性 (r=-0.267,P=0.009).
- 最初的分析显示血清尿酸与患者死亡率 (r=0.247,P=0.013) 之间存在显著的关系,在多变量分析后,这种关系失去了意义.
结论:
- 血清尿酸水平与急性心力衰竭中的利尿剂使用显著相关.
- 在调整其他因素后,住院死亡率与入院时的血清尿酸水平没有显著的关系.
- 血清尿酸可以作为生物标志物,反映急性心力衰竭管理中的利尿剂需求.
相关概念视频
01:11Renal Failure: Dose Adjustments
94
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
01:16Antihypertensive Drugs: Action of Diuretics
703
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
703
01:17Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:28Renal Drug Excretion: Tubular Secretion
189
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
189